T1	Pharmacological_substance 45 55	tacrolimus
N1000 	Reference T1 MeSH:D016559	tacrolimus
T2	Pharmacological_substance 69 91	proton pump inhibitors
N1001 	Reference T2 MeSH:D054328	proton pump inhibitors
T3	Pharmacological_substance 151 155	PPIs
N1002 	Reference T3 MeSH:D054328	PPIs
T4	Pharmacological_substance 160 170	tacrolimus
N1003 	Reference T4 MeSH:D016559	tacrolimus
T7	Pharmacological_substance 468 478	tacrolimus
N1004 	Reference T7 MeSH:D016559	tacrolimus
T8	Pharmacological_substance 483 493	omeprazole
N1005 	Reference T8 MeSH:D009853	omeprazole
T9	Pharmacological_substance 495 507	esomeprazole
N1006 	Reference T9 MeSH:D064098	esomeprazole
T10	Pharmacological_substance 517 529	lansoprazole
N1007 	Reference T10 MeSH:D064747	lansoprazole
T12	Pharmacological_substance 852 862	tacrolimus
N1008 	Reference T12 MeSH:D016559	tacrolimus
T13	Pharmacological_substance 933 943	tacrolimus
N1009 	Reference T13 MeSH:D016559	tacrolimus
T14	Pharmacological_substance 973 976	PPI
N1010 	Reference T14 MeSH:D054328	PPI
N1011 	Reference T14 MeSH:D054328	PPI
T15	Pharmacological_substance 811 815	PPIs
N1012 	Reference T15 MeSH:D054328	PPIs
T16	Subject 819 846	organ transplant recipients
T17	Subject 543 590	an 18-yr-old female kidney transplant recipient
T19	Subject 95 124	a kidney transplant recipient
T21	Subject 605 646	a CYP 2C19 extensive (normal) metabolizer
T24	Subject 282 325	patients who are classified as CYP 2C19 PMs
T11	Manner_cue 13 24	significant
T26	Manner_cue 237 248	significant
